Live Feed

Delayed 3m

Press · Analyst · Insider · Buys · SEC · Financials

Signed out · 3-min delay · Sign up for real-time

PR12:55:38·3h·Technology·
$CHOW
ChowChow Cloud International Holdings Limited Provides Response to Unusual Market Action
SINGAPORE, Aug. 29, 2026 (GLOBE NEWSWIRE) -- ChowChow Cloud International Holdings Limited ("Chowchow", the "Company") (NYSE:CHOW) announced today that the Company had become aware of unusual trading activity in its ordinary shares on the NYSE American LLC (the "NYSE American") on August 12, 2026 and August 27, 2026. The Company is issuing this press release pursuant to Section 401(d) of the NYSE American Company Guide. The Company has made inquiries and has been unable to determine whether corrective actions are appropriate at this time. The Company is further announcing that there has been no material development in its business and affairs not previously disclosed or, to its knowledge,
PR11:00:00·5h·Health Care·
$BMY
Bristol Myers Squibb Presents Data Up to Five Years Reinforcing the Long-Term Efficacy and Safety of Camzyos (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) at the European Society of Cardiology (ESC) Congress 2026
New single-arm, open-label data extend the body of evidence supporting consistent clinical benefit and safety with Camzyos, adding to the longest-running clinical development experience for a cardiac myosin inhibitor (CMI) in symptomatic oHCM Additional presentations at ESC Congress build upon the established effectiveness and safety profile of Camzyos in real-world settings Bristol Myers Squibb (NYSE:BMY) today presented results from the EXPLORER-LTE cohort of the MAVA-LTE study (NCT03723655) in a late-breaker presentation at the European Society of Cardiology (ESC) Congress 2026 in Munich, Germany. EXPLORER-LTE is the largest and longest evaluation of symptomatic obstructive hypertrop
PR10:30:00·5h·Health Care·
$CYTK
Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026
Additional Results from ACACIA-HCM Demonstrate Improvements in Cardiac Structure and Diastolic Function in Patients with Non-Obstructive HCM New Analysis of MAPLE-HCM Finds Aficamten Outperformed Metoprolol Across Pre-Trial Treatment Groups in Patients with Obstructive HCM SOUTH SAN FRANCISCO, Calif., Aug. 29, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that additional results from ACACIA-HCM (Assessment Comparing Aficamten to Placebo on Cardiac Endpoints In Adults with Non-Obstructive HCM) and MAPLE-HCM (Metoprolol vs Aficamten in Patients with LVOT Obstruction on Exercise Capacity in HCM) were presented in a Late Breaking Clinical Session at the Eu
PR08:21:22·8h·Health Care·
$TENX
Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026
In patients with a baseline 6MWD below the trial median of 333 meters, treatment with TNX-103 resulted in a 26.3-meter improvement compared to placebo (p = 0.0112) In the same patient population, TNX-103 produced a 47% reduction in NT-proBNP (p < 0.0001) and a 4.9 mmHg reduction in RVSP (p = 0.009) compared to placebo With full statistics analysis now complete, Company confirms TNX-103’s biological effects include marked reductions in pulmonary artery pressure and NT-proBNP, a biomarker reflecting increased cardiac wall stress. Results will inform protocol population enrichment and changes to overall registrational path CHAPEL HILL, N.C., Aug. 29, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeu
INSIDER21:53:58·18h·Finance·
$JEF
CEO Handler Richard B was granted 75,531 shares, increasing direct ownership by 0.60% to 12,625,397 units (SEC Form 4)
4 - Jefferies Financial Group Inc. (0000096223) (Issuer)
INSIDER21:53:12·18h·Finance·
$JEF
President Friedman Brian P was granted 29,016 shares, increasing direct ownership by 1% to 2,037,263 units (SEC Form 4)
4 - Jefferies Financial Group Inc. (0000096223) (Issuer)
INSIDER21:52:12·18h·Finance·
$JEF
EVP, CFO Larson Matthew Scott was granted 746 shares, increasing direct ownership by 0.75% to 99,756 units (SEC Form 4)
4 - Jefferies Financial Group Inc. (0000096223) (Issuer)
INSIDER21:51:28·18h·Consumer Discretionary·
$VTSI
Director Barber Grant bought $10,136 worth of shares (3,350 units at $3.03), increasing direct ownership by 16% to 24,392 units (SEC Form 4)
4 - VirTra, Inc (0001085243) (Issuer)
INSIDER21:50:59·18h·Finance·
$JEF
Director Weiler Melissa was granted 165 shares, increasing direct ownership by 0.41% to 40,147 units (SEC Form 4)
4 - Jefferies Financial Group Inc. (0000096223) (Issuer)
INSIDER21:51:40·18h·Finance·
$JEF
EVP and General Counsel Sharp Michael J. was granted 746 shares, increasing direct ownership by 0.44% to 168,409 units (SEC Form 4)
4 - Jefferies Financial Group Inc. (0000096223) (Issuer)
INSIDER21:49:19·18h·Finance·
$JEF
Director O Kane Michael T was granted 538 shares, increasing direct ownership by 0.41% to 133,030 units (SEC Form 4)
4 - Jefferies Financial Group Inc. (0000096223) (Issuer)
INSIDER21:49:57·18h·Finance·
$JEF
Director Ellis-Kirk Matrice was granted 165 shares, increasing direct ownership by 0.52% to 32,147 units (SEC Form 4)
4 - Jefferies Financial Group Inc. (0000096223) (Issuer)
INSIDER21:48:35·18h·Finance·
$JEF
Director Beyer Robert D was granted 501 shares, increasing direct ownership by 0.44% to 113,257 units (SEC Form 4)
4 - Jefferies Financial Group Inc. (0000096223) (Issuer)
INSIDER21:37:03·18h·Telecommunications·
$OPTU
Large owner Subin Neil S bought $2,454,822 worth of shares (3,032,354 units at $0.81) (SEC Form 4)
4 - Optimum Communications, Inc. (0001702780) (Issuer)
INSIDER21:36:41·18h·Telecommunications·
$OPTU
New insider Subin Neil S claimed ownership of 16,516,955 shares (SEC Form 3)
3 - Optimum Communications, Inc. (0001702780) (Issuer)
INSIDER21:35:06·18h·Health Care·
$NTRA
PRESIDENT, CHIEF BUS. OFFICER Fesko John was granted 20,000 shares and sold $2,095,411 worth of shares (6,517 units at $321.53) as part of a pre-agreed trading plan, increasing direct ownership by 7% to 197,257 units (SEC Form 4) (tax liability)
4 - Natera, Inc. (0001604821) (Issuer)
INSIDER21:30:10·18h·Industrials·
$EVTL
SEC Form 4 filed by Chief Executive Officer Simpson Stuart
4 - Vertical Aerospace Ltd. (0001867102) (Issuer)
INSIDER21:01:49·19h·Health Care·
$BIVI
Chief Medical Officer Palumbo Joseph M bought $10,461 worth of shares (4,843 units at $2.16), increasing direct ownership by 406% to 6,036 units (SEC Form 4)
4 - BIOVIE INC. (0001580149) (Issuer)
INSIDER21:01:21·19h·Health Care·
$BIVI
Director Chappell Amy Suzon bought $1,570 worth of shares (727 units at $2.16) (SEC Form 4)
4 - BIOVIE INC. (0001580149) (Issuer)
INSIDER21:00:04·19h·Consumer Discretionary·
$MRM
Chief Executive Officer Eguchi Kouji disposed of 79,945 shares, decreasing direct ownership by 4% to 1,797,515 units (SEC Form 4)
4 - Medirom Healthcare Technologies Inc. (0001819704) (Issuer)